Plain-English translation of NCT04441203 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether a small implanted sensor called CardioMEMS, which continuously monitors pressure levels in your heart, can help manage heart failure better than standard clinic visits alone. Half of the participants will receive the CardioMEMS sensor implant and use a home app to track their own heart data with remote nurse support, while the other half will receive usual heart failure clinic care. The study will follow both groups for 12 months to see which approach reduces hospitalizations and helps patients feel better.
Many people with heart failure end up in the hospital repeatedly, which is hard on patients and the healthcare system. This trial is testing whether giving patients real-time information about their heart's pressures โ combined with remote support from a nurse โ could help them catch problems early and avoid hospitalizations.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you are randomly selected for the sensor group, you will have a minor surgical procedure to implant the CardioMEMS device in a blood vessel in your lung โ a procedure that takes about 30 minutes. You'll then use a small home transmitter and smartphone app to share your heart pressure readings daily, and a nurse clinician will monitor your progress remotely. If you are in the standard care group, you will attend regular appointments at the specialized heart failure clinic. Both groups will be followed for 12 months with check-ins to compare how well each approach works.
AI-generated summary from trial data ยท Jun 28, 2026 ยท Not medical advice
Canada